Hims Hers Health Reports First Quarter 2026 Results Key Takeaways from the Latest Earnings Release Lowenstein Sandler Bolsters MA Practice with Partner Ivan Presant in New York Palvella Therapeutics Reports Positive Phase 2 Data for QTORIN Rapamycin in Cutaneous Venous Malformations Seadrill SDRL Q1 2026 Earnings Surprise EPS 011 Up Significant Innovative ISSC Crushes Q1 2026 Estimates EPS 026 Tops Views Immix Biopharma IMMX Declines 158 Amid Market Weakness 20260515 Spring SVIV Stalls at 1000 Consolidation Phase 20260515 Silver Rallies While Gold Eases as Precious Metals Show Divergence Mirion Technologies MIR Drops 235 Key Support at 1756 20260515